Devices such as IUDs are the most effective means of birth control, but few women use them because of the up-front costs, according to a story from the San Francisco Chronicle on Friday.
The story reports a wide range of costs for birth control among uninsured women, from $9 a month for generic pills to $90 a month for some newer brands. And getting a doctor to insert long-term devices such as IUDs can cost anywhere from $600 to $1,000.
According to ...
continue reading...Bayer has about 11,300 lawsuits pending from “persons alleged to have suffered personal injuries, some of them fatal” as a result of using the birth control pills Yasmin, Beyaz, and Yaz and their generic versions. And the company is expecting even more.
That’s from Bayer’s annual report, assessing the company’s status for 2011. The report provides a summation of the legal troubles the company has been dealing with over its oral contraceptives, which according to the lawsuits, cause an increased risk ...
continue reading...According to Bloomberg, German corporation Bayer is bidding on Pfizer’s animal-health unit.
Bayer’s chief financial officer said last month that the company planned to cut its debt by $1.3 billion to give it more flexibility for a potential takeover.
According to the report, the Pfizer unit could fetch between $14 billion and $18 billion.
See the report here:
Bayer is the manufacturer of Yaz, Yasmin, Beyaz, and Ocella — birth control pills that contain the compound drospirenone.
Those pills have served as the ...
continue reading...Shannon Pettypiece of Bloomberg Television provides some context for the recent national debates about birth control, pointing out that birth control constitutes “big business for big pharma.”
In a recent report, Ms. Pettypiece observed that Americans spent $5 billion last year for birth control. She said the German corporation Bayer gets about $1.5 billion a year from its drugs Yaz and Yasmin.
See the video here:
https://www.bloomberg.com/video/87718882/
Several studies show that Yaz, Yasmin, continue reading...
Bayer, the German corporation that manufactures birth control pills Yaz, Beyaz and Yasmin, could finance a “significant” acquisition using a combination of debt, equity and its portfolio assets, Bloomberg reports.
Bloomberg cites an interview with Bayer’s Chief Financial Officer Werner Baumann, who said the company would only sell one of its three units “on the merits of its own strategic assessment.”
“You will not find us in a situation where we say we want to buy this, therefore we have to sell ...
continue reading...The federal Food and Drug Administration has approved a new, lower-dose formulation of a Bayer corporation drug used to treat menopausal symptoms.
The drug Angeliq contains drospirenone, a synthetic progestogen that may elevate the levels of potassium in the body.
“We are pleased by the approval of this important new lower-dose option for menopausal women,” Bayer HealthCare Pharmaceuticals VP and head of U.S. medical affairs Pamela Cyrus said. “The availability of the new lower dose of Angeliq supports current guidelines which recommend ...
continue reading...
